We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+24.52%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$11.9B
AUM Growth
-$101M
(-0.84%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-14.47%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,692
New
482
Increased
315
Reduced
482
Closed
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$187M |
| 3 |
AstraZeneca
AZN
|
+$163M |
| 4 |
Lockheed Martin
LMT
|
+$162M |
| 5 |
S&P Global
SPGI
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$234M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Mercado Libre
MELI
|
+$136M |
| 4 |
Procter & Gamble
PG
|
+$128M |
| 5 |
Shopify
SHOP
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 11.12% |
| 5 | Communication Services | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Hilton Grand Vacations
HGV
$3.49B
| $433K | ﹤0.01% |
13,812
-9,775
| -41% | -$255K |
|
1152
Churchill Downs
CHDN
$6.17B
| $429K | ﹤0.01% |
4,400
-12,740
| -74% | -$1.16M |
|
1153
Cabot Corp
CBT
$4.46B
| $425K | ﹤0.01% |
9,463
-1,605
| -15% | -$66.6K |
|
|
OSB
1154
DELISTED
Norbord Inc.
OSB
| $423K | ﹤0.01% |
+9,786
| New | +$358K |
|
1155
AnaptysBio
ANAB
$1.69B
| $420K | ﹤0.01% |
19,550
-44,487
| -69% | -$1.08M |
|
1156
Strategy Inc
MSTR
$37.3B
| $420K | ﹤0.01% |
10,810
-32,200
| -75% | -$752K |
|
1157
Merit Medical Systems
MMSI
$5.45B
| $418K | ﹤0.01% |
7,537
-29,433
| -80% | -$1.52M |
|
|
QTS
1158
DELISTED
QTS REALTY TRUST, INC.
QTS
| $418K | ﹤0.01% |
+6,762
| New | +$423K |
|
1159
Artivion
AORT
$1.4B
| $416K | ﹤0.01% |
17,604
-45,347
| -72% | -$919K |
|
1160
Graco
GGG
$13.4B
| $415K | ﹤0.01% |
5,740
-120,752
| -95% | -$8.08M |
|
|
NOAH
1161
Noah Holdings
NOAH
$588M
| $414K | ﹤0.01% |
+8,667
| New | +$280K |
|
1162
Southern Company
SO
$106B
| $411K | ﹤0.01% |
6,691
-1,128,678
| -99% | -$67.9M |
|
|
RDUS
1163
DELISTED
Radius Health, Inc.
RDUS
| $410K | ﹤0.01% |
22,960
-22,215
| -49% | -$334K |
|
|
CSW
1164
CSW Industrials
CSW
$5.65B
| $408K | ﹤0.01% |
+3,643
| New | +$364K |
|
1165
Stratasys
SSYS
$767M
| $408K | ﹤0.01% |
+19,692
| New | +$316K |
|
1166
Cal-Maine
CALM
$3.86B
| $405K | ﹤0.01% |
10,780
-13,360
| -55% | -$514K |
|
1167
First Commonwealth Financial
FCF
$2.18B
| $404K | ﹤0.01% |
36,894
-52,039
| -59% | -$499K |
|
|
CLCT
1168
DELISTED
Collectors Universe
CLCT
| $404K | ﹤0.01% |
+5,358
| New | +$364K |
|
|
OPI
1169
DELISTED
Office Properties Income Trust
OPI
| $402K | ﹤0.01% |
17,707
+7,005
| +65% | +$153K |
|
|
RAVN
1170
DELISTED
Raven Industries Inc
RAVN
| $402K | ﹤0.01% |
+12,161
| New | +$320K |
|
|
GRA
1171
DELISTED
W.R. Grace & Co.
GRA
| $402K | ﹤0.01% |
7,333
-144,336
| -95% | -$7.26M |
|
1172
Graham Holdings Company
GHC
$5.03B
| $395K | ﹤0.01% |
741
-3,702
| -83% | -$1.64M |
|
1173
Envista
NVST
$4.61B
| $394K | ﹤0.01% |
+11,692
| New | +$339K |
|
|
ECOL
1174
DELISTED
US Ecology, Inc.
ECOL
| $394K | ﹤0.01% |
+10,851
| New | +$376K |
|
|
EGRX
1175
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $393K | ﹤0.01% |
8,432
+3,679
| +77% | +$172K |
|
Similar funds
VAI
Voloridge Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Voloridge Investment Management held 1,692 positions worth $11.9B, down 0.84% from $12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Voloridge Investment Management withdrew a net $1.72B in Q4 2020, closing 413 positions and reducing 482 holdings. Its most notable exit was Wells Fargo, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in AstraZeneca worth $154M.
- Voloridge Investment Management's largest Q4 2020 buy was AstraZeneca: 1,542,881 shares worth $154M.
- Voloridge Investment Management added most to Microsoft in Q4 2020, an estimated $242M increase.
- Voloridge Investment Management's biggest Q4 2020 reduction was Citigroup, cutting an estimated $234M.
- Voloridge Investment Management fully exited Wells Fargo in Q4 2020, selling an estimated $111M.
- Voloridge Investment Management's ten largest holdings make up 17% of its $11.9B portfolio in Q4 2020.
- Voloridge Investment Management opened 482 new positions and closed 413 in Q4 2020.
- Voloridge Investment Management's portfolio value fell 0.84% quarter-over-quarter to $11.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.